Zelira Therapeutics Ltd.ASX: ZLD

Significant Anti-Cancer Effect Observed in Studies

· Issued by Zelira Therapeutics Ltd.

Filed with ASX · · 3 pages · English

• Positive results provide support for Zelda to continue its programme of study evaluating its THC-rich medical cannabis formulations as anti-cancer therapeutics Specifically, this initial study compared the anti-tumour responses of pure tetrahydrocannabinol (THC) versus the Zelda Therapeutics formulation of THC-rich oil and at the same time compare the potency against a standard chemotherapy drug

Zelira Therapeutics Ltd. on 6ix

Earlier from Zelira Therapeutics

Later from Zelira Therapeutics

All Zelira Therapeutics news releases